Dietary soy protein reduces early renal disease progression and alters prostanoid production in obese fa/fa Zucker rats

Journal of Nutritional Biochemistry

Volumn 19, Issue 4, 2008, Pages 255-262

  Hwang, Sun Young ^a   Taylor, Carla G ^a,b   Zahradka, Peter ^a   Bankovic Calic, Neda ^a   Ogborn, Malcolm R ^a,b   Aukema, Harold M ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

6 keto prostaglandin F1 ; Dietary soy protein; Glomerular hypertrophy; Obesity associated nephropathy; Prostanoids; Thromboxane B2

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EGG WHITE; MESSENGER RNA; PROSTAGLANDIN E2; PROSTANOID; SOYBEAN PROTEIN; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVITY; FOOD INTAKE; GENE EXPRESSION; GENOTYPE; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS FILTRATION; KIDNEY HYPERTROPHY; KIDNEY MASS; LEAN BODY WEIGHT; MALE; NONHUMAN; OBESITY; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEINURIA; RAT; TREATMENT OUTCOME; ZUCKER RAT;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CYCLOOXYGENASE 2; DIETARY PROTEINS; GENOTYPE; KIDNEY; KIDNEY DISEASES; MALE; OBESITY; PROSTAGLANDINS; RATS; RATS, ZUCKER; SOYBEAN PROTEINS;

ANIMALIA; RATTUS;

EID: 39849097675     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.03.001     Document Type: Article

References (40)

1. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 21 (2006) 463-470
2. de Jong P.E., Verhave J.C., Pinto-Sietsma S.J., Hillege H.L., and PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 26 Suppl 4 (2002) S21-S24
3. Phillips A., Janssen U., and Floege J. Progression of diabetic nephropathy. Insights from cell culture studies and animal models. Kidney Blood Press Res 22 (1999) 81-97
4. Breyer M.D., and Breyer R.M. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 279 (2000) F12-F23
5. Imig J.D. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 279 (2000) F965-F981
6. Nasrallah R., and Hebert R.L. Prostacyclin signaling in the kidney: implications for health and disease. Am J Physiol Renal Physiol 289 (2005) F235-F246
7. Lobstein T., Baur L., Uauy R., and IASO International Obesity Task Force. Obesity in children and young people: a crisis in public health. Obes Rev 5 Suppl 1 (2004) 4-104
8. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States 1999-2004. JAMA 295 (2006) 1549-1555
9. Ejerblad E., Fored C.M., Lindblad P., Fryzek J., McLaughlin J.K., and Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol 17 (2006) 1695-1702
10. Stahl R.A., Kudelka S., and Helmchen U. High protein intake stimulates glomerular prostaglandin formation in remnant kidneys. Am J Physiol 252 (1987) F1088-F1094
11. Yanagisawa H., Morrissey J., Kurihara N., Wada O., and Klahr S. Effects of dietary protein on glomerular eicosanoid production in rats with bilateral ureteral obstruction. Proc Soc Exp Biol Med 207 (1994) 234-241
12. Yanagisawa H., and Wada O. Effects of dietary protein on eicosanoid production in rat renal tubules. Nephron 78 (1998) 179-186
13. Yao B., Xu J., Qi Z., Harris R.C., and Zhang M.Z. Role of renal cortical cyclooxygenase-2 expression in hyperfiltration in rats with high-protein intake. Am J Physiol Renal Physiol 291 (2006) F368-F374
14. Teixeira S.R., Tappenden K.A., and Erdman Jr. J.W. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice. J Nutr 133 (2003) 673-678
15. Williams A.J., and Walls J. Metabolic consequences of differing protein diets in experimental renal disease. Eur J Clin Invest 17 (1987) 117-122
16. Ogborn M.R., Bankovic-Calic N., Shoesmith C., Buist R., and Peeling J. Soy protein modification of rat polycystic kidney disease. Am J Physiol 274 (1998) F541-F549
17. Cahill L., Peng C.Y., Bankovic-Calic N., Sankaran D., Ogborn M., and Aukema H.M. Dietary soy protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring. Br J Nutr 97 (2007) 77-84
18. Maddox D.A., Alavi F.K., Silbernick E.M., and Zawada E.T. Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney Int 61 (2002) 96-104
19. Stephenson T.J., Setchell K.D., Kendall C.W., Jenkins D.J., Anderson J.W., and Fanti P. Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin Nephrol 64 (2005) 1-11
20. Bosch J.P., Saccaggi A., Lauer A., Ronco C., Belledonne M., and Glabman S. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med 75 (1983) 943-950
21. Kontessis P.A., Bossinakou I., Sarika L., Iliopoulou E., Papantoniou A., Trevisan R., et al. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care 18 (1995) 1233
22. Fair D.E., Ogborn M.R., Weiler H.A., Bankovic-Calic N., Nitschmann E.P., Fitzpatrick-Wong S.C., et al. Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats. J Nutr 134 (2004) 1504-1507
23. Kontessis P., Jones S., Dodds R., Trevisan R., Nosadini R., Fioretto P., et al. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 38 (1990) 136-144
24. Kitazato H., Fujita H., Shimotomai T., Kagaya E., Narita T., Kakei M., et al. Effects of chronic intake of vegetable protein added to animal or fish protein on renal hemodynamics. Nephron 90 (2002) 31-36
25. Dhaene M., Sabot J.P., Philippart Y., Doutrelepont J.M., and Vanherweghem J.L. Effects of acute protein loads of different sources on glomerular filtration rate. Kidney Int Suppl 22 (1987) S25-S28
26. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
27. Weibel E. Practical methods for biological morphometry. Stereological methods (1979), Academic Press, London 41-45
28. Hirose K., Osterby R., Nozawa M., and Gundersen H.J. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 21 (1982) 689-695
29. Warford-Woolgar L., Peng C.Y., Shuhyta J., Wakefield A., Sankaran D., Ogborn M., et al. Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys. Am J Physiol Renal Physiol 290 (2006) F897-F904
30. Aukema H.M., Adolphe J., Mishra S., Jiang J., Cuozzo F.P., and Ogborn M.R. Alterations in renal cytosolic phospholipase A2 and cyclooxygenases in polycystic kidney disease. FASEB J 17 (2003) 298-300
31. Rozen S., and Kaletsky SH. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics methods and protocols: methods in molecular biology (2000), Humana Press, Totowa, NJ 365-386
32. Trujillo J., Ramirez V., Perez J., Torre-Villalvazo I., Torres N., Tovar A.R., et al. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 288 (2005) F108-F116
33. Iwasaki K., Gleiser C.A., Masoro E.J., McMahan C.A., Seo E.J., and Yu B.P. The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol 43 (1988) B5-B12
34. Dey A., Maric C., Kaesemeyer W.H., Zaharis C.Z., Stewart J., Pollock J.S., et al. Rofecoxib decreases renal injury in obese Zucker rats. Clin Sci (Lond) 107 (2004) 561-570
35. Komers R., Zdychova J., Cahova M., Kazdova L., Lindsley J.N., and Anderson S. Renal cyclooxygenase-2 in obese Zucker (fatty) rats. Kidney Int 67 (2005) 2151-2158
36. Xu Z.G., Lanting L., Vaziri N.D., Li Z., Sepassi L., Rodriguez-Iturbe B., et al. Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation 111 (2005) 1962-1969
37. Fujihara C.K., Antunes G.R., Mattar A.L., Andreoli N., Malheiros D.M., Noronha I.L., et al. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney. Kidney Int 64 (2003) 2172-2181
38. Horiba N., Kumano E., Watanabe T., Shinkura H., Sugimoto T., and Inoue M. Subtotal nephrectomy stimulates cyclooxygenase 2 expression and prostacyclin synthesis in the rat remnant kidney. Nephron 91 (2002) 134-141
39. Komers R., Lindsley J.N., Oyama T.T., Schutzer W.E., Reed J.F., Mader S.L., et al. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 107 (2001) 889-898
40. Wang J.L., Cheng H.F., Shappell S., and Harris R.C. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Kidney Int 57 (2000) 2334-2342